摘要
目的探讨胸腔镜下纵隔肿瘤切除术治疗纵隔肿瘤的疗效及安全性。方法选取医院2019年6月至2020年6月收治的纵隔肿瘤患者72例,随机分为观察组及对照组,各36例。观察组患者采用胸腔镜下纵隔肿瘤切除术治疗,对照组患者采用常规开胸手术治疗。结果观察组术后并发症总发生率为5.56%,明显低于对照组的5.00%(P<0.05);观察组手术和术中出血量、切口长度、总住院时间均明显少于对照组(P<0.05);观察组疼痛评分明显低于对照组(P<0.05)。结论采用胸腔镜下纵隔肿瘤切除术治疗纵隔肿瘤患者可降低临床并发症的发生率,可减少术中出血、有效缩短手术时间,加快患者康复速度,值得推广。
Objective To investigate the efficacy and safety of thoracoscopic resection in the treatment of mediastinal tumors.Methods Totally 72 patients with mediastinal tumor in our hospital from June 2019 to June 2020 were randomly divided into the observation group and the control group,36 cases in each group.The observation group was treated with thoracoscopic mediastinal tumor resection,while the control group was treated with conventional thoracotomy.Results The total incidence of postoperative complications in the observation group was 5.56%,which was significantly lower than 5.00%of the control group(P<0.05),the amount of bleeding,incision length and total hospitalization time in the observation group were less than those in the control group(P<0.05),the pain score of the observation group was lower than that of the control group(P<0.05).Conclusion Thoracoscopic resection in the treatment of patients with mediastinal tumor can reduce the incidence of clinical complications,it can reduce intraoperative bleeding,effectively shorten the operation time,and accelerate the recovery speed of patients.
出处
《中国药业》
CAS
2020年第S01期106-107,共2页
China Pharmaceuticals
关键词
纵隔肿瘤
临床疗效
安全性
胸腔镜下纵隔肿瘤切除术
mediastinal tumor
clinical efficacy
safety
thoracoscopic resection for mediastinal tumor
